Try our Advanced Search for more refined results

Deals Rumor Mill: Biogen, Aetna, Enbridge

By Benjamin Horney (August 2, 2016, 6:04 PM EDT) -- A number of drugmakers, including Merck & Co. Inc. and Allergan PLC, have interest in buying biotechnology company Biogen Inc., The Wall Street Journal reported on Tuesday. According to the report, Biogen has a market value of around $68 billion, and the company might have no interest in being taken over. No formal talks have begun, the report noted, and any informal discussions have merely been preliminary in nature. Biogen, which is known for its multiple sclerosis drugs, posted sales of roughly $10.8 billion in 2015, an 11 percent increase from the prior year, the report added....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!